Triple-negative BC (TNBC) is a particular subtype of BC, which is diagnosed by lacking the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), and accounts for approximately 15–20% of all BC [2]. Here, ERBB2 is linked to breast cancer.